v3.25.2
Net Loss Per Class A Common Share Attributable to Maravai LifeSciences Holdings, Inc. (Tables)
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Net Loss Per Share
The following table presents the computation of basic and diluted net loss per Class A common share attributable to the Company for the periods presented (in thousands, except per share amounts):
Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
Net loss$(69,837)$(18,420)$(122,690)$(41,100)
Less: loss attributable to common non-controlling interests
30,246 8,631 53,154 19,233 
Net loss attributable to Maravai LifeSciences Holdings, Inc.
$(39,591)$(9,789)$(69,536)$(21,867)
Weighted average Class A common shares outstanding
144,236 135,842 143,833 134,088 
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., basic and diluted$(0.27)$(0.07)$(0.48)$(0.16)
Summary of Dilutive Securities Excluded from Computation of Loss Per Share
The following table presents potentially dilutive securities excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive for the periods presented (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
Restricted stock units
13,3602,1733,5662,399
Stock options4,5504,0214,5504,021
Shares estimated to be purchased under the employee stock purchase plan
2,025152,02510
Shares of Class B common stock110,684110,684110,684110,684
Total130,619116,893120,825117,114